General discussion, page-4763

IHL is at an early stage but it knows what it has under the bonnet. CBD works, Hydro works and the "cocktail" invivo results show that
675 outperforms either.
Then we have CTE in the headlines, Opioids in the spotlight, sleep apnea, etc etc.
We are being steered towards a NYSE listing, opening our gems to the "big league"
This time next year we will look back at March this year and think "what were we ever worried about"